NCT01345240
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +15 more
- Locations
-
- GSK Investigational Site Ouagadougou, Burkina Faso
- GSK Investigational Site Kumasi, Ghana
Clinical trial condition
Explore clinical trials studying Hepatitis. Study availability and eligibility vary by location and protocol.
NCT01345240
NCT03038763
NCT02647281
NCT02569710
NCT02600325
NCT02115321
Not specified
NCT01326546
NCT03995485
NCT01499498
NCT02618928